Analyst Ratings for AbCellera Biologics (ABCL)
ABCL Rating Summary
ABCL Price Target Summary
- Highest: $38.00 (Berenberg)
- Lowest: $6.00 (KeyBanc)
- Average: $22.71
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$22.71 (+366.4%)
* Over Last 12-Mos
Rating Score: 9.1 / 10
Percentile Rank: 90%
Avg. $ Target:
$22.71 (+366.4%)
* Over Last 12-Mos
Rating Score: 9.1 / 10
Percentile Rank: 90%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/5/2023 | KeyBanc | Scott Schoenhaus | New Coverage | Overweight (N/A) |
6.00 (N/A) |
4.83 (4.87) |
0.83% | Details |
| 11/6/2023 | Benchmark | Robert Wasserman | Downgrade | Hold (Buy) |
N/A (N/A) |
4.70 (4.87) |
3.62% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
